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The immunobiology of the mammalian
epididymis: the black box is now open!
Rachel Guiton, Joelle Henry-Berger and Joël R Drevet*
Abstract
Spermatozoa represent an immunologic challenge for the mammalian males. They are produced long after the
establishment of the immune library of the individual and harbor specific spermatic antigens that are found
nowhere else in other organs, tissues and cells. Consequently, spermatozoa are somehow “foreign” to the male
adaptive immune system. In order not to elicit autoimmune responses that would be detrimental for male fertility,
spermatozoa should be either physically separated from the adaptive immune response and/or, the immune
system challenged by spermatic antigens must be efficiently silenced. Within the mammalian male genital tract it
becomes more and more obvious that a range of strategies are at stake to ensure that the immune-stranger
spermatozoa do not constitute an immunological issue. In this review the focus will be on the immune status of
the epididymis tubule, in which spermatozoa that have left the testes will mature for approximately 2 weeks and
may be stored for prolonged period of time. How the epididymal immune environment compares to that of the
testis and what are the immune regulatory processes at work in the epididymal compartment will only be briefly
described. Instead, this review will focus on recent data that highlight epididymal immune regulatory actors that
partly explain/illustrate the rather complicated, fragile but nevertheless robust immune environment of the
epididymis.
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Résumé
Les spermatozoïdes constituent un défi immunologique pour le mammifère mâle qui les fabrique. Elaborés
longtemps après l’établissement de la librairie immunitaire de l’individu, ils portent des antigènes spécifiques de la
lignée germinale qui leur confèrent un caractère “étranger” de nature à solliciter le système immunitaire. Afin de ne
pas engager de réponses auto-immunes anti-spermatozoïde dont l’issue serait délétère pour la fertilité de l’individu,
les spermatozoïdes doivent être gardés à l'abri des cellules immuno-compétentes, ou, si une réponse auto-
immune anti-spermatozoïde est engagée, cette dernière doit être rendue silencieuse. Au sein du tractus génital
mâle il apparaît de plus en plus clairement que différentes stratégies sont à l’œuvre afin d’empêcher que le
spermatozoïde ne “challenge” le système immunitaire du mâle. Cette revue présente le statut immunologique de
l’épididyme des mammifères dans lequel les spermatozoïdes qui ont quitté le testicule vont maturer pendant
environ 2 semaines et être éventuellement stockés pour des périodes de temps variables. En quoi la situation
immunologique de l’épididyme est-elle comparable ou différente de celle du testicule et quels sont les mécanismes
immunitaires en action dans ce tubule seront présentés de façon non exhaustive. Une attention particulière sera
donnée à des résultats récents qui mettent en avant quelques acteurs clefs de l’immuno-modulation et de la
tolérance immune au sein de ce tissu épididymaire.
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Introduction
The mammalian immune system consists in a very
elaborate network involving organs, tissues, cells and
molecules that interact to determine what is self (and
in good integrity) that should be ignored from what is
non-self (or self that has gone awry) and should be
eliminated. The distinction self/non-self is not always
that clear-cut and there are situations where tolerance
is necessary. One classical example is the tolerance
that should be given to commensal bacteria populating
the intestinal compartment.
In mammals, tolerance is established at two different
levels and at two different periods. Central tolerance is
set up in the primary lymphoid organs (bone marrow
and thymus) essentially prior to birth by the absence of
release of auto-reactive immune competent T and B cells.
The second level of tolerance called peripheral tolerance is
realized continuously in the tissues by means of various
immunosuppressive activities and/or tissular organizational
arrangements (see Table 1). The situation of immune priv-
ilege towards spermatozoa established in the mammalian
male genital tract falls in that second category.
Although the biological challenge is the same (to avoid
autoimmune responses against sperm antigens), the
different tissues of the male genital tract do not solve it
the same way. As for many other physiological aspects,
the testis is the site of the male genital tract where the
immune situation has been most studied these last years
and where we have a quite clear view of the innate and
adaptive immune mechanisms at work. Since the present
review focuses on the immune environment of the epididy-
mis tubule it will not cover in detail the situation in the
testis. Recent extensive reviews are however available for
interested readers [1-3]. Briefly, the first major factor
restricting the engagement of immune responses towards
spermatozoa in the seminiferous tubules is the tight
organization of the epithelium. The high efficiency of
the blood-testis-barrier (BTB) isolates the luminal com-
partment of the seminiferous tubule from the interstitial
compartment surveyed by immune cells [4]. The semin-
iferous epithelium is therefore particularly protected
from the passage of immune cells and immune regulatory
molecules because of the specialized tight junctions
that lock Sertoli cells to one another. In addition, these
isolating junctions are found at the basal-lateral membrane
domain, a situation that is not that of classical mucosal
epithelia and in particular not that of the epididymis
epithelium. In that respect the immune situation of the
epididymis tubule resembles more that of the intestine
epithelium with the difference that, up to now, no one has
found in the epididymis tubule specialized mucosa-associ-
ated lymphoid formations such as the Gut-Associated
Lymphoid Tissue (GALT) in which the adaptive immune
response is partly orchestrated.
The immune context of the epididymal epithelium
Clinical observations support the idea that the mammalian
epididymis immune control is rather different from that
of the testis. Firstly, epididymitis is largely more frequent
than orchitis and the latter very often leaks to epididymo-
orchitis while the reverse is not that frequent. Secondly,
acute epididymitis is essentially provoked by retrograde
invasion of urethral bacterial pathogens in sexually trans-
mitted disease (STD) situations, while orchitis is more
frequently due to blood-transmitted pathogens (for a
recent review see: [3]). This suggests that despite their
luminal connection through the efferent ducts, the immune
regulatory mechanisms that control both the seminiferous
and epididymal tubules are probably not the same and
that the proximal part of the epididymis (ie the caput)
may function as a control point limiting the proliferation
of ascending pathogens. Third, the blood-epididymis barrier
Table 1 Comparison of central versus peripheral tolerance mechanisms
When? Where? How?
Central tolerance Fetal life (setting) Thymus (T lymphocytes) Apoptotic death (deletion) of immature self
antigen-specific lymphocytes
Throughout life (maintenance) Bone marrow (B lymphocytes)
Peripheral tolerance Throughout life Whole organism
(except thymus and bone marrow)
Apoptotic death (deletion) of mature self
antigen-sepcific lymphocytes
OR
Functional inactivation (anergy)
OR
Suppression of lymphocyte activation and
functions by regulatory T cells (Tregs) or by
other immunosuppressive effectors such as
IDO, kynurenines, cytokines (IL-10), growth
factors (TGF-β1)…
Central tolerance is a very early mechanism that is maintained throughout life. It takes place in the primary lymphoid organs (thymus and bone marrow) and
consists in the deletion of self antigen-specific B and T cells as soon as they are produced. Peripheral tolerance is set up after central tolerance and is maintained
in the whole organism throughout life. Three mechanisms can act: deletion and anergy of mature self antigen-specific lymphocytes, and effector T cell (Th17, Th1,
Th2) suppression by regulatory T cells (Tregs) or by immunosuppressive molecules (indoleamine 2,3-dioxygenase = IDO, kynurenines, IL-10, TGF-β1…).
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(BEB) (for a recent report on the mammalian BEB see: [5])
appears to be much weaker compared to the BTB since it
is quite frequent to observe intra-epithelial immune cells
as well as luminal leucocyte infiltrations in the epididymis
when compared to the seminiferous tubules [3]. Immuno-
globulins too have been shown to access the epididymal
luminal compartment [3]. In addition, within the different
cell types that constitute the epididymis epithelium it is
yet not clear whether or not some of these cell subtypes
have immunological functions. This is particularly the
case of the so-called halo and basal cells, the latter cell
type having been shown to express macrophage-specific
markers, at least in the mouse model [3].
Antigen presenting cells (APC) in the epididymis epithelium
Interestingly, it was recently shown that the mouse epi-
didymis epithelium exhibits a dense network of dendritic-
like cells [6] with a stellate morphology and cytoplasmic
projections that may reach the luminal compartment and,
consequently, be in a position to sample its content. This
finding somehow changes our vision of the epididymis
tubule that, up to now, was considered as a territory devoid
of antigen presentation events. It brings forward the idea
that the epididymis is active in maintaining self-tolerance
towards spermatozoa and that it is not solely under the
protective influence of the peripheral tolerance established
in the testis, as it was often suggested earlier. Again, this
observation reinforces the idea that the epididymis tubule
resembles the intestinal situation where dendritic cells were
shown to play an important role through their ability to
orchestrate protective immunity and immune tolerance in
the host [7].
The epididymal dendritic-like cells (eDCs) were shown to
be particularly dense in the proximal caput epididymidis
where the dendrites seem to protrude beyond the apically
located tight junctions constituting the BEB. Further down
the epididymis tubule, the eDCs were found less numerous
and their dendrites less invasive within the epididymal
epithelium. In the cauda epididymidis, the eDCs were
shown to have no dendrites and to be restricted to the basal
compartment of the epithelium [6]. These characteristics
of distribution suggest that the eDCs are in a position of
sampling the luminal content of the proximal epididymis,
but not further down the epididymis tubule.
In recent years, dendritic cells (DCs) have received a
lot of attention and are now thought to have a key role in
bridging innate immunity with the induction of adaptive
immunity [8]. In addition, as previously mentioned, DCs
have been shown to orchestrate both central tolerance
and peripheral tolerance [8]. Several categories of DCs
were described starting with classical DCs (cDCs), which
exhibit a strong antigen-presentation capacity and therefore
are major T-cell inducers. In relation with their high ability
to present antigens cDCs are characterized by their high
expression of MHC class II antigens and integrin CD11c
on their surface. It is interesting to note that these features
were found on the epididymal DCs [6]. In addition, Da Silva
et al. reported that, at least in vitro, the epididymal DCs
have strong antigen-presenting abilities [6] reinforcing the
idea that they are of the cDC type. The in vivo activity of
the epididymal DCs was recently further illustrated by the
recent report from the same group that after efferent duct
ligation (known to provoke apoptosis in the epididymal
proximal epithelium), epididymal DCs engulf and evacuate
apoptotic cells to maintain the integrity of the epididymis
tubule (Tegan Smith, selected oral communication at
the 2013 International Congress of Andrology, Melbourne
Australia). While doing so, it was observed that the
eDCs dendrites retract. These behaviors at least illustrate
the phagocytic capacity of the eDCs in the very proximal
segment of the epididymis.
The second well-characterized group of DCs is the
plasmacytoid DCs (pDCs) that are essentially found in
the circulation and in the peripheral lymphoid tissues.
These pDCs are not good antigen-presenting cells and con-
sequently they express low levels of MHC class II antigens
as well as the co-stimulatory molecules important for T-cell
activation. Upon activation pDCs have been shown to
secrete large amounts of IFN-α and IFN-β, which suggests
that they play an important role in anti-viral immune
responses [9]. Whether this subtype of DCs exists in the
epididymis is not known because in mouse, in contrast to
the human situation, pDCs also express at their surface
the CD11c marker. Therefore, Da Silva et al. in their
pioneering study [6] could not discriminate between cDC
and pDC in the epididymis.
Not all DCs are stimulatory DCs since it was shown
that regulatory DCs also exist in various settings. At the
beginning it was thought that immature DCs could induce
immunosuppression and tolerance [10]. However, it was
recently shown in different tissues and situations that
mature tolerogenic DCs do exist. Of note is the report
that gut DCs expressing the CD103 marker were strongly
involved in inducing tolerance through their ability to
promote the differentiation of immunosuppressive T-
regulatory cells from naïve T-cells (the so-called T-regs
secreting the immunosuppressive effectors TGF-β and
IL-10) [11]. The capacity of these gut CD11c+CD103+ DCs
to induce T-reg cells was further associated with their abil-
ity to express the immunosuppressive enzyme indoleamine
2,3-dioxygenase (IDO: EC 1.13.11.42) ([12,13] and see
below). Da Silva et al. have shown that at least part of
the epididymal CD11c+ DCs they have brought forward in
the epididymis epithelium were also positive for CD103
which strongly supports the idea that, similarly to the
gut situation, tolerogenic DCs are present [6]. Rather
intriguing was the observation (by Da Silva’s group and
ourselves) that despite the fact that caput epididymal
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DCs were shown to share common markers with intestinal
tolerogenic DCs (since both were CD11c+ and CD103+ [6])
they were not found, at least by immunocytochemical
approaches, to express the immunosuppressive effector
indoleamine 2,3-dioxygenase that partly explains the
tolerogenic action of DCs in the gut [14] as well as in
other settings [13]. This observation was quite puzzling
since IDO activity has long been known to be high in the
mammalian epididymis [15]. The next chapter will focus
on that particular immunomodulatory molecule that was
recently investigated further in the mouse epididymis.
In summary, at least two populations of DCs are present
in the epithelium and interstitial compartments of the
mouse epididymis, classical immune response-activating
DCs and tolerogenic DCs. How these different eDCs
are distributed along the epididymis tubule remains to
be shown both in normal and infected situations. The
fact that the caput segments show more eDCs having a
stellate/dendriform morphology compared to the cauda
territory, is in agreement with the idea that tolerance
towards sperm antigens should be at first efficiently
maintained in the proximal part of the organ when
spermatozoa enter the epididymis tubule. In the meantime
the caput luminal compartment is also a territory that
should be efficiently surveyed both for abnormal sperm
cells and non-self ascending pathogens. For the latter, this
survey is particularly important in order to protect the
testis from the retrograde invasion of sexually transmitted
pathogens. The eDCs, by efficiently sampling the caput
luminal content, are likely to participate to these phenom-
ena. It would be interesting to test whether in epididymal
ascending infectious situations the cauda eDCs are
activated or not. The DCs situation in the epididymis
fits rather well the concept of “division of labor” within
dentritic cell subsets which proposes that different subsets
of DCs are at work to modulate the fine equilibrium
between immune survey and tolerogenesis [8-10]. On
these grounds, we speculate that luminal antigen presen-
tation within that proximal tubule is probably quite active
with “immunogenic” or also called “presenting” or else
“stimulatory” eDCs sampling efficiently the epididymal
luminal compartment. Efficient immune monitoring
could also explain why this epididymal territory is so
rarely concerned by epithelial tumorigenic events since
the appearance of “foreign” tumor antigens would rapidly
engage the immune system and the elimination of the
tumorigenic cells. In the meantime, outside abnormal
situations (such as infections and tumors) tolerogenic/
regulatory epididymal DCs would ensure that the immune
response towards spermatic antigens remains low. In
addition, in that context of efficient antigen presentation in
the proximal epididymis tolerance towards sperm antigens
could also be established through the priming of particular
subsets of T-cells that have immunosuppressive roles.
Epididymal-specific expression of immunomodulatory
effectors
Indoleamine 2,3-dioxygenase and its downstream
kynurenine metabolites Indoleamine 2,3-dioxygenase is
the first and rate-limiting enzyme in tryptophan catabolism
through the kynurenine pathway [16]. It is a ubiquitously
expressed cytoplasmic protein activated by interferons
(IFNs). In recent years IDO has received a lot of attention
and there is a large body of data showing that IDO
plays key immunomodulatory roles in classical immune
responses but also in particular situations such as fetal
tolerance, tumor immune resistance, and regulation of
autoimmune responses [17].
IDO was associated with the epididymis as early as the
eighties [15] when it was shown that IDO activity was
surprisingly high in epididymis extracts. Intriguingly, IDO
expression in the epididymis was found to be constitutive
and independent of its classical inflammatory cytokine
inducer (IFN-γ) since IDO expression was identical when
WT mice were compared to mice deficient for IFN-γ
signaling [18]. This observation suggested that the epididy-
mis is in a particular state of anti-inflammatory response
since IDO is classically considered a component of early
response to inflammation and infection. Besides knowing
the immunomodulatory function attributed to IDO espe-
cially in down-regulating the adaptive T cell-dependent
immune response, it was speculated that the intense
epididymal expression of IDO was likely to participate
in the establishment of an immunotolerant environment
towards immune-challenging sperm antigens. In recent
studies we have investigated further the expression and
the roles of IDO in the mammalian epididymis using both
WT and IDO1-deficient mouse models [19,20]. We have
shown that IDO1, but not IDO2 and TDO that belong to
the same family and have the same roles, is preferentially
expressed in the mouse epididymal epithelium. The minor
roles played by the low expression of IDO2 and TDO in
the epididymis was confirmed by the fact that when IDO1
expression was knocked-out (ie in the IDO1-deficient
model) the level of kynurenines, the products of IDO
activity, dramatically decreased. This suggests that in
the absence of IDO1 there is no compensation by the
other members of the family [19]. In addition, TDO was
not found in the same cell types since it was localized in
the smooth muscle cells lining the epididymal duct as
well as in transiting spermatozoa [21].
IDO1 expression in the epididymis is regionalized since
it was shown to be caput-restricted. Within the caput,
IDO1 expression starts posterior to segment 1 and peaks
up at segments 3 and 4. It then goes down in segment 5
to undetectable levels further down the epididymis tubule
epithelium [21-23]. At the cellular level, IDO1 expression
was shown to concern preferentially principal and apical
cells within the epididymal epithelium [21,22]. As said
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above via immunohistochemical approaches it was not
found to localize in the eDCs where we logically thought
it could be with reference to the gut situation where IDO
expression is a feature of the CD11c+CD103+ DCs [14].
This observation suggests that the principal/apical epi-
didymal cells somehow cooperate with the immune
cells to regulate the immune environment. This is not
a completely new situation since it was shown elsewhere
that lung epithelial cells might contribute to protective
tolerance via a (TLR3/TRIF)-dependent pathway conver-
ging on IDO [24].
We have very recently shown that when IDO1 is not
present, ie in the Ido1−/− mouse model, it drives the
caput epididymidis in a more pronounced inflammatory
state as evidenced by the significant increase of several
inflammatory cytokines and chemokines, the induction of
cyclo-oxygenases COX1 and COX2 and their associated
lipid intermediates [20]. Nevertheless, despite the slightly
more inflamed situation, the immune status of the tissue
remains under control since we never observed acute
inflammatory events such as the occurrence of granuloma.
This suggests that some mechanisms are switched on to
back-up the missing IDO activity. We also have shown
in the same study that the absence of IDO1 expression
and of its downstream kynurenine metabolites modifies
slightly the epididymal representation in the various T
cell subsets as it is logically expected. IDO is known to
be a strong inducer of the immunosuppressive regulatory
T-reg cell lineage at the expense of the Th17 inflammatory
subset [25]. Thus, quite logically, in its absence we have
shown that the differentiation of the Th17 T cell subset
from naïve T cells is promoted [20]. Consequently, we
also demonstrated that the stimulation of the Th17 in-
flammatory cells influences the Th1/Th2 equilibrium
in favor of the Th1 sub-lineage [20]. This was confirmed by
the cytokine profile since the Th1 inflammatory cytokines
(TNF-α, IFN-γ, IL-1β and IL-6) were all significantly
increased in Ido1−/− caput extracts while the typical Th2
cytokine IL-4 was not [20]. These observations were in
agreement with the conventional roles of IDO and of its
downstream kynurenine metabolites on immune reponses.
Promotion of a Th1-driven response in the epididymis
of Ido1−/− animals was to be expected in the context of
a weaker immunotolerant environment against sperm
antigens that should stimulate a Th1-mediated auto-
immune reaction [26]. In addition, it has been reported
that kynurenines including 3-hydroxy-arachidonic acid
(3-OH-AA) and 3-hydroxykynurenine (3-OHK) inhibit
the actions of Th1 cells and enhance the action of Th2
cells [27]. Other reports have also shown that stimula-
tion of IDO activity in dendritic cells diminishes Th1
response [28]. Conversely, it was also reported that
1-methyltryptophan-mediated inhibition of IDO activity
enhances Th1-associated inflammation [29]. Therefore,
in the absence of IDO1 and of its downstream metabo-
lites, as it is the case in the epididymis of the Ido1−/− an-
imals [7], a shift of the Th1/Th2 equilibrium towards
Th1 was to be expected.
It was also quite interesting to note that the absence of
IDO1 expression in the epididymis was associated with a
weaker capacity of the epididymis to realize an efficient
quality control function on transiting sperm cells. This
was evidenced by the fact that in the Ido1−/− model we
recorded in the cauda storage compartment twice the
number of spermatozoa as in control WT animals. This
was neither associated with a difference in the efficiency
of spermatogenesis nor with a difference in sexual activity
[20]. The greater sperm counts found in Ido1−/− cauda
epididymides were essentially due to an increase in sperm-
atozoa having abnormal morphology as well as necrotic
spermatozoa that, in a normal context, should have been
disposed of during epididymal descent [19]. These obser-
vations reinforce the rather controversial idea that sperm
selection during epididymal descent is a process that is
partly under the control of the immune response [30]. To
support the involvement of immune cells and immune
responses in the epididymal selection of spermatozoa is
our observation that the increased defective sperm counts
found in Ido1−/− cauda epididymides were paralleled with
a very significant decrease in the cauda fluid leucocyte
content [19].
Cyclo-oxygenases, Cox2 and Cox1 It is worth noting
that the epididymis is rather unusual as it is character-
ized by its constitutive high expression of COX2 [31,32].
In any other tissue, COX2 expression is solely induced
by inflammatory stimuli. The constitutive expression
of both COX2 and IDO1 recorded in the mouse caput
epididymidis reinforces the idea that this territory is in
a permanent semi-inflammatory state characteristic of
immunotolerant settings. We have shown that both
COX1 and COX2 expression levels were up-regulated
in Ido1−/− caput extracts compared to WT animals [20].
Although it is commonly believed that the constitutive
isoform COX1 has little or no involvement in regulat-
ing immune responses [33], there are recent reports
suggesting that COX1 is actively involved in immuno-
regulation [34] and that part of its effect is mediated
via IL-17 production by Th17 cells [35]. Our data are
consistent with these statements since we observed in
the caput epididymides of Ido1−/− animals a shift in the
Th17/Treg equilibrium towards Th17 cells and an associ-
ated increase in the concentration of IL-17 [20].
Factors of the TGF-β family The immunosuppressive
functions of TGF-β are well recognized and documented.
There are two ways by which TGF-β suppresses immune
responses either through the inhibition of inflammatory
Guiton et al. Basic and Clinical Andrology 2013, 23:8 Page 5 of 10
http://www.bacandrology.com/content/23/1/8
cell functions or via the promotion of T-reg cell functions
(for a recent review see [36]). It is interesting to note
that in the slightly more inflamed IdoI−/− epididymis we
recorded an increase in the activation of the Smad3
intracellular effector of the TGF-β pathway [20]. It is
possible that this TGF-β signal constitutes part of the
mechanisms by which the immunosuppressive response
of the epididymal tissue is maintained in the absence of
IDO1 and kynurenines. It may also explain why in the
absence of IDO and kynurenines we do not lose the T-reg
subset. Indeed, TGF-β (more specifically TGF-β1) was
shown to act as a T-reg autocrine and paracrine inducer
[37]. Which cell type(s) in the epididymis epithelium of
Ido1−/− animals is (are) involved in that surge of TGF-β
signaling remains to be clarified. It is already known that
the mammalian as well as the primate epididymides
express significant levels of the different TGF-β isoforms
in a region-specific manner [38-41]. More precisely, in
the marmoset monkey, TGF-β1 was found expressed in
epididymal apical epithelial cells while its receptor was
found on the adjacent principal cells suggesting that
paracrine TGF-β1 signaling could occur within the
epididymal epithelium [39].
It is also worth noting that via comparative gene ex-
pression array analyses we revealed Bmp8a to be among
the genes most strongly induced in Ido1−/− caput epididy-
mides. BMP8a belongs to the TGF-β family and was previ-
ously shown to participate in the differentiation of the
caput epididymal epithelium [42,43]. Interestingly, lack of
BMP8a and BMP7 expression in Bmp8a−/− and Bmp8a/
Bmp7−/− mice provoked inflammatory situations in the
caput epididymides of these animals characterized by the
occurrence of sperm-mediated granulomas [43]. These
observations support the idea that a TGF-β family
member such as BMP8a might participate in the immune
control of the adult caput epididymidis. It is thus possible
that through an anti-inflammatory autocrine/paracrine
signaling cascade involving the TGF-β/BMP/activin
pathway the Ido1−/− epididymal epithelium partly recovers
its immune balance by maintaining the T-reg population
and by negatively controlling the expansion of the Th17
sub-lineage.
IL-10 IL-10 is an immunosuppressive cytokine which
along with TGF-β1 constitutes the signature of the T-reg
lineage and suppresses the Th1/Th2/Th17-mediated
immune response. We observed a significant increase
in IL-10 production in the Ido1−/− caput extracts that
may also participate in the new immune equilibrium
reached by the tissue. Although T-reg cells are the
major provider of IL-10, it has been shown lately that
several other cell types can also produce it; including
Th1, Th2, cytotoxic T cells, B lymphocytes, mast cells,
mononuclear phagocytes, APCs as well as TDN cells
[44,45]. More investigations will be necessary to identify
which cell(s) type(s) in the caput epididymidis of Ido1−/−
animals is (are) responsible for the increased production
of IL-10. In this respect, it is of interest to note that the
principal cells of the epididymis epithelium have been
shown earlier to express IL-10 and to have the capability
to over-express IL-10 in some abnormal pathologic situa-
tions [46]. If this is verified, epididymal epithelial IL-10 ex-
pression could be yet another way by which autoantigenic
spermatozoa are protected from immune destruction.
Retinoic acid/retinol Recently immunologists started to
explore the mechanisms by which vitamin A controls the
innate and adaptive immune systems. It was shown that
certain intestinal APC subsets including DCs metabolize
vitamin A into retinoic acid (RA) and enhance the TGF-β-
dependent conversion of naïve T cells into regulatory T cells
(for a recent review see [11]). In addition, RA synthesis
by APC was shown to influence the migration of T and
B cells as well as IgA into mucosal sites. Beside DCs,
non-hematopoietic cells of the gut such as epithelial and
stromal cells have been shown to also synthetize RA and
participate in these migratory and homing processes of
immune cells and immunoglobulins. Therefore, epithelial
cells once again somehow cooperate with APCs to control
local immune responses in both inflammation and toler-
ance (for a recent review see [47]). In this context, it is
interesting to remember that RA metabolites have long
been shown to play an important role in the mammalian
epididymis [48,49]. In situation of vitamin A deficiency as
is the case in transgenic animals expressing a dominant
negative form of retinoic acid receptor α it was reported
that the cauda epididymidis is dysfunctional leading to a
situation of infertility [50]. Thus, trafficking of retinoids is
likely to be a regulator of epididymal function. Knowing
the recent roles devoted to RA metabolites in modulating
immune responses it would not be surprising to find
out that RA participates in the immune equilibrium of
the epididymis. One interesting point is the rather recent
observations bringing forward the interplay between RA
and TGF-β signaling in inducing T-reg differentiation [51].
Presence of peculiar lymphoid cell sub-lineages
In the epididymis, in contrast to the testis, both intra-
epithelial and interstitial immune cells are rather frequent
(for a recent review see [2]). Regarding lymphocytes, the
prevalent view is that overall they are more frequent in
the proximal epididymis (caput) compared to the distal
regions. Within the organ itself, it was reported that
the interstitium preferentially contains CD4+ T cells
(of the assistant and regulatory types, Ths and T-reg)
while the epididymal epithelium shows more CD8+ T cells
(of the cytotoxic type, Tc) (reviewed in [2]). Our recent
investigations, reported in [20] have used FACS analysis to
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look at the distribution of leucocytes in caput epididymidis
tissue samples dissociated by collagenase treatment in
both WT and Ido1−/− animals. In total agreement with
previous data, our analyses revealed that B cells and CD3+
T cells were rather rare in the caput epididymal tissue and
that most of the lymphoid cells were triple negative (CD3-
CD4-CD8-) cells so most likely macrophages, DCs or/and
NK cells [52]. Regarding the few CD3+ cells, they were es-
sentially found to be of the CD3+ double negative type
(devoid of CD4 and CD8), the so-called CD3+DN or TDN.
Recently, TDNs have been added to the increasing list
of T cells that exert regulatory functions similar to
those of classical T-reg (CD4+CD25+FoxP3+) cells [53-57].
Interestingly, TDNs were recently shown to be involved in
the prevention of autoimmune responses engaged in the
inflamed epididymis after vasectomy [58]. In agreement
with the observation that the epididymal immune equilib-
rium of the Ido1−/− animals is somehow well preserved we
have not seen any significant change in the representation
of the various leucocyte lineages in the caput epididymides
of this genotype.
Immune assistance of the epididymal white adipose tissue
In rodents, the epididymis is surrounded by a specific
white adipose tissue (WAT) called the epididymal WAT
or EWAT. It was interesting to note that one of the associ-
ated phenotypes of the Ido1−/− animals was a significant
reduction of the volume of the EWAT at 6 months of age
which was confirmed and even accentuated in animals
aged 12 months, compared to WT animals at the same
ages (JHB & RG, unpublished data). It is tempting to
propose that the proximal EWAT somehow participates
in the mechanisms that regulate the inflammatory status
of the Ido1−/− caput epididymidis. At this stage of our
investigations, it however cannot be excluded that the
proximal EWAT loss is just a collateral effect of the
caput inflammation. How could the EWAT participate
in the immune control of the epididymis? It is well
established that the WAT constitutes an immune and
inflammatory cell reservoir [59] and that each adipose
depot presents, according to its localization, different
immunological properties [60]. In that respect, it is
interesting to note that the EWAT is highly enriched in
anti-tumoral NK and NKT cells, characteristics shared
with epithelial tissues where these immune cells help in
maintaining tissue integrity, antitumoral surveillance,
defense against pathogens and in regulating inflammation
[61,62]. Murine adipose stem cells (mASCs) were recently
shown to down-regulate both Th1-driven autoimmune
and inflammatory responses in Crohn’s disease (a chronic
disease characterized by severe Th1 cell-driven inflamma-
tion of the colon) [63]. In that particular report, mASCs
were shown to decrease a wide panel of inflammatory
cytokines and chemokines, to increase interleukin-10 levels,
to impair Th1 cell expansion, and to induce/activate both
in vitro and in vivo CD4+CD25+FoxP3+ regulatory T cells
with a suppressive impact on Th1 effector responses. In the
light of these observations, it is possible that the EWAT
ASCs play such an immunomodulatory role in the Ido1−/−
animals at the expense of their local adipogenic function.
Concurring with Chu et al. (2010) [64], who speculated that
the EWAT pad might have a facilitative/supportive role in
the production and the maturation of sperm via the local
and direct action of unknown EWAT-produced factors, we
propose to extend this supportive local role of the EWAT
to the maintenance of the immune balance in the caput
epididymidis. However, it should be remembered that
this situation is particular to rodents since there is no
mention of such adipose depots in larger mammals,
including human.
The particularities of the epididymal initial segment
of the caput
Once again the caput segment 1 or initial segment of the
epididymis is distinct. Unlike the rest of the tubule, the
initial segment is highly vascularized and presents a dense
network of capillaries irrigating the entire surface of the
segment. This is responsible for its pink appearance easily
visible upon dissection of the tissue when the conjonctiva
is removed. This segment is also rather more heavily
drained by lymphatic vessels than the rest of the tubule
([65] and JHB & RG, unpublished data). The well-
developed lymphatic drainage of the caput epididymidis
distinguishes it from other tissues, such as the brain in
which an immune privileged situation is associated with
absence of lymphatic drainage. Therefore, in this segment
1, if one associates the presence of conventional presenting
dendritic cells with a dense lymphatic system it is likely
that what is taken up and processed by the eDCs will
end up in the nearest local lymph nodes where presenta-
tion to immune competent cells should take place. How
the immunogenic and tolerogenic responses are then or-
chestrated in this territory will have to be investigated.
Most likely, the concept of division of labor within the
different subsets of APCs will explain the situation. For
example, outside infectious events classical eDCs may
target T regulatory cells while upon pathogen-mediated
inflammatory situations, inflammatory eDCs could dialog
with effector T cells. Both the cytokine environment and
the type of mature eDCs could then drive the immune
equilibrium response from a tolerant state towards an
immunogenic state. At this stage, we view the initial
segments of the epididymis as a very important checkpoint
of the tubule where an extremely fine tuning of immune
mechanisms exists to serve three major goals: 1) mainten-
ance of tolerance towards sperm antigens, 2) last watch for
ascending pathogens that could invade the high security
gonad quarter, 3) elimination of abnormal spermatozoa.
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Conclusions
Recent investigations have started to open the black
box of the mammalian epididymal immune physiology.
The initial hypotheses that epididymal luminal antigen
presentation was absent and that solely innate phenomena
were in charge of the immune watch of this territory are
now challenged by the evidence that professional antigen
presenting cells such as dendritic cells (DCs) are present
throughout the tissue. Because recent advances ascribe
various subsets of DCs fundamental roles in connecting in-
nate immunity with adaptive immunity and in maintaining
the balance between immunity and tolerance, as it is the
case in the intestine, it is likely that the epididymal DCs
will prove to play a crucial role in the immune equilibrium
of the epididymis. Apparently, together with these classical
immune cells, the epididymal epithelial cells also participate
in the immune control of the organ. Besides the well doc-
umented ability of the epididymis epithelium to synthesize
and secrete antimicrobicidal molecules which were not
the topic of this review, the strong epithelial expression of
the immunomodulatory IDO1 protein is to date the best
illustration of this epithelial assistance in the control of
the immune adaptive response. TGF-β signaling, IL-10
production, retinoic acid metabolism, the presence of
peculiar T cell subsets such as the regulatory T-reg and
TDN may represent other ways by which the epididymal
Figure 1 Hypothesis of the setting and maintenance of immune tolerance to spermatozoa in the epididymis. It seems that various
mechanisms/cells/molecules are at work in the different epididymis segments. The first segment (S1) is filled with a dense network of dendritic
cells able to reach the lumen. They could thus potentially sample luminal antigens (and among them sperm antigens) to present them to local
(epithelium-resident T cells) or distant (proximal lymph node-resident T cells) immunoregulatory cells. The lack of immunomodulatory molecules
could explain the slight inflammation we previously described in this segment. Spermatozoa entry into the epididymal tubule induces the
expression of indoleamine 2,3-dioxygenase (IDO1), which can be found as soon as the second segment (S2), and of its enzymatic products, the
kynurenines. The combination of numerous dendritic cells and IDO1 expression leads to a reduction in the local inflammation observed in the
initial segment. IDO1 expression reaches its maximum in the third segment (S3) leading to a strong increase in kynurenine concentrations. The
later induce the differentiation of regulatory T lymphocytes which produce immunomodulatory molecules such as TGF-β1 or IL-10, ending in the
suppression of effector T cells (Th17 or Th1). In the same time, the loss of dendrites on the dendritic cells suggests that at this level of the
epididymis tubule they may become accessory cells in the maintenance of tolerance.
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epithelium contributes to maintain the rather complicated
immune situation of the tissue (summarized in Figure 1).
Local crosstalk with the surrounding white adipose depot
might also represent one side of the immune environment
of the epididymis, especially in the caput region. The
situation may appear complex but one has to remember
that nowhere else the immune system has to face such a
challenging act. Robust protection against invading ascend-
ing pathogens, immune tolerance towards immunogenic
spermatic antigens and controlled autoimmune processes
to ensure sperm selection and quality control are the three
facets of the epididymis immunologic equation. It is obvi-
ous that we are still far from understanding the rather finely
tuned immune context of the epididymis that could be
translated into clinical applications. More investigations are
definitely necessary. It is however unfortunate that very few
research groups are presently involved in such research.
Understanding the fine tuning of immune responses in the
epididymis has obvious clinical relevance to the field of
mammalian fertility. It could bring insights that reach far
beyond reproductive issues since as said above the peculiar
immune monitoring of the epididymis may well explain
why this epithelium is so refractory to carcinogenesis which
by nature represents an immunologic failure.
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